Vaderis Therapeutics AG (Vaderis), a clinical stage biotechnology company focusing on treatments for rare diseases associated with vascular malformations, today announces that the US Food and Drug ...
NavaDerm Partners, a portfolio company of BelHealth Investment Partners, LLC, has sold Dermatology and Surgery Associates to Schweiger Dermatology Group. No financial terms were disclosed. DSA was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback